167 related articles for article (PubMed ID: 29749503)
21. Identification of key candidate genes involved in melanoma metastasis.
Chen J; Wu F; Shi Y; Yang D; Xu M; Lai Y; Liu Y
Mol Med Rep; 2019 Aug; 20(2):903-914. PubMed ID: 31173190
[TBL] [Abstract][Full Text] [Related]
22. Identification of critical genes associated with human osteosarcoma metastasis based on integrated gene expression profiling.
Fan H; Lu S; Wang S; Zhang S
Mol Med Rep; 2019 Aug; 20(2):915-930. PubMed ID: 31173206
[TBL] [Abstract][Full Text] [Related]
23. Expression of miR‑542‑3p in osteosarcoma with miRNA microarray data, and its potential signaling pathways.
Li Z; Yao JN; Huang WT; He RQ; Ma J; Chen G; Wei QJ
Mol Med Rep; 2019 Feb; 19(2):974-983. PubMed ID: 30569116
[TBL] [Abstract][Full Text] [Related]
24. Integrated analysis of differentially expressed genes and pathways in triple‑negative breast cancer.
Peng C; Ma W; Xia W; Zheng W
Mol Med Rep; 2017 Mar; 15(3):1087-1094. PubMed ID: 28075450
[TBL] [Abstract][Full Text] [Related]
25. Identification of Key Genes and Pathway for Ovarian Neoplasms Using the OVDM1 Cell Line Based on Bioinformatics Analysis.
Yin S; Du J; Zhang J; Zhang X; Ma K
Med Sci Monit; 2019 Jun; 25():4305-4313. PubMed ID: 31177266
[TBL] [Abstract][Full Text] [Related]
26. Bioinformatics analysis of key differentially expressed genes in well and poorly differentiated endometrial carcinoma.
Zang Y; Dong M; Zhang K; Tian W; Wang Y; Xue F
Mol Med Rep; 2018 Jul; 18(1):467-476. PubMed ID: 29749513
[TBL] [Abstract][Full Text] [Related]
27. Data Mining of Differentially Expressed Genes in Ovarian Epithelial Carcinoma: Implications in Precise Medicine.
Zhao J; Gao H; He Y
Curr Top Med Chem; 2021 Oct; 21(14):1285-1300. PubMed ID: 34238161
[TBL] [Abstract][Full Text] [Related]
28. Identification of Significant Gene Signatures and Prognostic Biomarkers for Patients With Cervical Cancer by Integrated Bioinformatic Methods.
Li X; Tian R; Gao H; Yan F; Ying L; Yang Y; Yang P; Gao Y
Technol Cancer Res Treat; 2018 Jan; 17():1533033818767455. PubMed ID: 29642758
[TBL] [Abstract][Full Text] [Related]
29.
Deng Y; Ma H; Hao J; Xie Q; Zhao R
Biomed Res Int; 2020; 2020():8604340. PubMed ID: 32420375
[TBL] [Abstract][Full Text] [Related]
30. Identification of genes and pathways associated with MDR in MCF-7/MDR breast cancer cells by RNA-seq analysis.
Yang M; Li H; Li Y; Ruan Y; Quan C
Mol Med Rep; 2018 May; 17(5):6211-6226. PubMed ID: 29512753
[TBL] [Abstract][Full Text] [Related]
31. Construction of a Competitive Endogenous RNA Network in Uterine Corpus Endometrial Carcinoma.
Ouyang D; Li R; Li Y; Zhu X
Med Sci Monit; 2019 Oct; 25():7998-8010. PubMed ID: 31650984
[TBL] [Abstract][Full Text] [Related]
32. A Five-Gene Expression Signature Predicts Ovarian Cancer Metastasis.
Gu Y; Zhang S
Crit Rev Eukaryot Gene Expr; 2021; 31(5):41-50. PubMed ID: 34591389
[TBL] [Abstract][Full Text] [Related]
33. Systematic prediction of key genes for ovarian cancer by co-expression network analysis.
Wang M; Wang J; Liu J; Zhu L; Ma H; Zou J; Wu W; Wang K
J Cell Mol Med; 2020 Jun; 24(11):6298-6307. PubMed ID: 32319226
[TBL] [Abstract][Full Text] [Related]
34. Gene expression profiling of epithelial ovarian cancer reveals key genes and pathways associated with chemotherapy resistance.
Zhang M; Luo SC
Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909918
[TBL] [Abstract][Full Text] [Related]
35. SSX expression in gynecological cancers and antibody response in patients.
Hasegawa K; Koizumi F; Noguchi Y; Hongo A; Mizutani Y; Kodama J; Hiramatsu Y; Nakayama E
Cancer Immun; 2004 Dec; 4():16. PubMed ID: 15603546
[TBL] [Abstract][Full Text] [Related]
36. Bioinformatics prediction and analysis of hub genes and pathways of three types of gynecological cancer.
Liu Y; Yi Y; Wu W; Wu K; Zhang W
Oncol Lett; 2019 Jul; 18(1):617-628. PubMed ID: 31289534
[TBL] [Abstract][Full Text] [Related]
37. Identification and analysis of genes associated with epithelial ovarian cancer by integrated bioinformatics methods.
Gui T; Yao C; Jia B; Shen K
PLoS One; 2021; 16(6):e0253136. PubMed ID: 34143800
[TBL] [Abstract][Full Text] [Related]
38. Five candidate biomarkers associated with the diagnosis and prognosis of cervical cancer.
Han HY; Mou JT; Jiang WP; Zhai XM; Deng K
Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33616161
[TBL] [Abstract][Full Text] [Related]
39. Bioinformatics Analysis Highlights Five Differentially Expressed Genes as Prognostic Biomarkers of Cervical Cancer and Novel Option for Anticancer Treatment.
Cui H; Ma R; Hu T; Xiao GG; Wu C
Front Cell Infect Microbiol; 2022; 12():926348. PubMed ID: 35782114
[TBL] [Abstract][Full Text] [Related]
40. In silico identification of key genes and signaling pathways targeted by a panel of signature microRNAs in prostate cancer.
Baruah MM; Sharma N
Med Oncol; 2019 Apr; 36(5):43. PubMed ID: 30937635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
